LISA SULLIVAN to Cross-Sectional Studies
This is a "connection" page, showing publications LISA SULLIVAN has written about Cross-Sectional Studies.
Connection Strength
0.243
-
Association of Parental Obesity and Diabetes Mellitus With Circulating Adipokines in Nonobese Nondiabetic Offspring. J Am Heart Assoc. 2017 Jul 16; 6(7).
Score: 0.019
-
Prospective Relation of Circulating Adipokines to Incident Metabolic Syndrome: The Framingham Heart Study. J Am Heart Assoc. 2017 Jul 16; 6(7).
Score: 0.019
-
Circulating Adipokines and Vascular Function: Cross-Sectional Associations in a Community-Based Cohort. Hypertension. 2016 Feb; 67(2):294-300.
Score: 0.017
-
Association of soda consumption with subclinical cardiac remodeling in the Framingham heart study. Metabolism. 2015 Feb; 64(2):208-12.
Score: 0.016
-
Age of natural menopause and atrial fibrillation: the Framingham Heart Study. Am Heart J. 2012 Apr; 163(4):729-34.
Score: 0.013
-
Circulating vascular growth factors and central hemodynamic load in the community. Hypertension. 2012 Apr; 59(4):773-9.
Score: 0.013
-
Reference intervals for plasma L-arginine and the L-arginine:asymmetric dimethylarginine ratio in the Framingham Offspring Cohort. J Nutr. 2011 Dec; 141(12):2186-90.
Score: 0.013
-
Circulating insulin-like growth factor-1 and its binding protein-3: metabolic and genetic correlates in the community. Arterioscler Thromb Vasc Biol. 2010 Jul; 30(7):1479-84.
Score: 0.012
-
P-wave indices, distribution and quality control assessment (from the Framingham Heart Study). Ann Noninvasive Electrocardiol. 2010 Jan; 15(1):77-84.
Score: 0.011
-
Association of the endogenous nitric oxide synthase inhibitor ADMA with carotid artery intimal media thickness in the Framingham Heart Study offspring cohort. Stroke. 2009 Aug; 40(8):2715-9.
Score: 0.011
-
Vascular endothelial growth factor, its soluble receptor, and hepatocyte growth factor: clinical and genetic correlates and association with vascular function. Eur Heart J. 2009 May; 30(9):1121-7.
Score: 0.011
-
Associations of adiponectin, resistin, and tumor necrosis factor-alpha with insulin resistance. J Clin Endocrinol Metab. 2008 Aug; 93(8):3165-72.
Score: 0.010
-
Soft drink consumption and risk of developing cardiometabolic risk factors and the metabolic syndrome in middle-aged adults in the community. Circulation. 2007 Jul 31; 116(5):480-8.
Score: 0.010
-
Burden and prognostic importance of subclinical cardiovascular disease in overweight and obese individuals. Circulation. 2007 Jul 24; 116(4):375-84.
Score: 0.010
-
Relations of serum phosphorus and calcium levels to the incidence of cardiovascular disease in the community. Arch Intern Med. 2007 May 14; 167(9):879-85.
Score: 0.009
-
Insulin resistance, the metabolic syndrome, and incident cardiovascular events in the Framingham Offspring Study. Diabetes. 2005 Nov; 54(11):3252-7.
Score: 0.008
-
Relative importance of borderline and elevated levels of coronary heart disease risk factors. Ann Intern Med. 2005 Mar 15; 142(6):393-402.
Score: 0.008
-
C-reactive protein, the metabolic syndrome, and prediction of cardiovascular events in the Framingham Offspring Study. Circulation. 2004 Jul 27; 110(4):380-5.
Score: 0.008
-
Framingham stroke risk profile and lowered cognitive performance. Stroke. 2004 Feb; 35(2):404-9.
Score: 0.007
-
Overweight and obesity as determinants of cardiovascular risk: the Framingham experience. Arch Intern Med. 2002 Sep 09; 162(16):1867-72.
Score: 0.007
-
Computing estimates of incidence, including lifetime risk: Alzheimer's disease in the Framingham Study. The Practical Incidence Estimators (PIE) macro. Stat Med. 2000 Jun 15-30; 19(11-12):1495-522.
Score: 0.006
-
Metabolic control and prevalent cardiovascular disease in non-insulin-dependent diabetes mellitus (NIDDM): The NIDDM Patient Outcome Research Team. Am J Med. 1997 Jan; 102(1):38-47.
Score: 0.005